GlassScriptPhysician profile
Tara L Becker
NPI 1598119398
$12,024.88
in general payments reported to CMS, 2019-2025
49 companies · $2,041 in 2025
The $2,041 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $138 · 2021: $572 · 2022: $2,267 · 2023: $3,804 · 2024: $3,201 · 2025: $2,041.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,461 · Travel and Lodging: $569 · Education: $16.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,460.76 |
| Travel and Lodging | $569.35 |
| Education | $16.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $1,326.70 | 2021-2025 | Briviact, Nayzilam, Fintepla |
| Abbvie INC. | $1,217.70 | 2021-2025 | Qulipta, Ubrelvy |
| Livanova USA, INC. | $1,205.03 | 2023-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Neurelis, INC. | $1,104.91 | 2020-2025 | Valtoco |
| Mdd US Operations, LLC | $744.34 | 2024 | Apokyn |
| Eisai INC. | $641.93 | 2021-2025 | |
| Sk Life Science, INC. | $566.33 | 2022-2025 | Xcopri |
| Lundbeck LLC | $466.91 | 2022-2025 | Vyepti, Rexulti |
| Pfizer INC. | $439.77 | 2023-2025 | |
| Acadia Pharmaceuticals INC | $404.88 | 2023-2025 | Nuplazid, Daybue |
| Emd Serono, INC. | $386.66 | 2022-2025 | Mavenclad |
| Biogen, INC. | $334.04 | 2021-2025 | Vumerity, Tysabri, Plegridy |
| Catalyst Pharmaceuticals, INC. | $306.06 | 2023-2025 | Fycompa |
| Otsuka America Pharmaceutical, INC. | $303.75 | 2023-2025 | Rexulti, Nuedexta |
| Genzyme Corporation | $240.02 | 2021-2025 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.